Skip to Main Content

Paper Details

Combining next-generation hormonal therapy with PARP inhibition in metastatic castration-resistant prostate cancer.
Lancet
0
2023
Author NameAffiliation
Wassim AbidaMemorial Sloan Kettering Cancer Center
Gerhardt AttardUniversity College London
  • 1 - 2

Datasets

Release 1.2